Integer To Showcase Latest Innovations In Neuromodulation Miniaturization During NANS 2024 Annual Meeting


(MENAFN- GlobeNewsWire - Nasdaq) Attendees Invited to Visit Integer at Booth #127

PLANO, Texas, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will join medtech leaders and innovators around the world in exhibiting at the North American Neuromodulation Society (NANS) Annual Meeting at Caesars Palace in Las Vegas from Jan. 18 – 21, 2024.

During NANS, attendees are invited to visit booth #127 to learn more about Integer's latest innovations and expanded capabilities in neuromodulation to enable the next generation of miniaturized active implantable devices.

“Through miniaturization, Integer is creating the next generation of differentiated platform technologies to accelerate and de-risk OEMs' path to market for novel implantable medical devices,” said Jim Stephens, President, CRM&N.“Our broad expertise in critical components, from batteries to fully integrated implantable pulse generator systems, coupled with our leadership position in active implantables uniquely positions Integer to deliver these advancements to our customers.”

NANS attendees can also learn more about Integer's Xcellion® Gen 3 Fast Charge (FC) Lithium Ion rechargeable implantable battery technology. Xcellion Gen 3 FC delivers best in class battery runtime and full re-charges in as little as 30 minutes.

Learn more about Integer at .

About Integer ®
Integer Holdings Corporation (NYSE:ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, vascular, portable medical and orthopedics markets. Integer provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, the Company develops batteries for high-end niche applications in energy, military, and environmental markets. The Company's brands include Greatbatch Medical ® , Lake Region Medical ® and Electrochem ® . Additional information is available at .

Investor Relations:
Andrew Senn
...
763.951.8312
Media Relations:
Kelly Butler
...
214.618.4216

MENAFN16012024004107003653ID1107727144


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.